ABSTRACT
Background – Male hypogonadism is a clinical and biochemical androgen insufficiency syndrome, becoming more prevalent with age. Exogenous testosterone is the first choice therapy, with several side effects, including negative feedback of the hypothalamic-pituitary-gonadal axis...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.